Similar articles

• [Psychiatric patients and QT interval monitoring].

  Girardin F, Gaspoz JM. Girardin F, et al. Rev Med Suisse. 2007 Apr 11;3(106):945-8. Rev Med Suisse. 2007. PMID: 17575970 Review. French.
• [QT interval prolongation and psychotropic drugs in children and adolescents: proposed guideline].

  van Aerde KJ, Kalverdijk LJ, Reimer AG, Widdershoven JA. van Aerde KJ, et al. Ned Tijdschr Geneeskd. 2008 Aug 9;152(32):1765-70. Ned Tijdschr Geneeskd. 2008. PMID: 18754307 Review. Dutch.
• Torsade de pointes induced by psychotropic drugs and the prevalence of its risk factors.

  Justo D, Prokhorov V, Heller K, Zeltser D. Justo D, et al. Acta Psychiatr Scand. 2005 Mar;111(3):171-6. doi: 10.1111/j.1600-0447.2004.00469.x. Acta Psychiatr Scand. 2005. PMID: 15701100 Review.
• Psychiatric medications and sudden cardiac death: putting the risk in perspective.

  Howland RH. Howland RH. J Psychosoc Nurs Ment Health Serv. 2015 Feb;53(2):23-5. doi: 10.3928/02793695-20150122-01. J Psychosoc Nurs Ment Health Serv. 2015. PMID: 25654571 Review.
• Clinical management of cardiovascular risks during treatment with psychotropic drugs.

  Glassman AH. Glassman AH. J Clin Psychiatry. 2002;63 Suppl 9:12-7. J Clin Psychiatry. 2002. PMID: 12088171 Review.